The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
November 26th 2024
Amgen’s MariTide achieved up to 20% average weight loss at 52 weeks without hitting a plateau in individuals with obesity or overweight.
November 16th 2024
HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP
Diabetes, Insulin Resistance Among Best Predictors of Premature Coronary Heart Disease in Women
January 20th 2021An analysis of the Women's Health Study indicates women with type 2 diabetes were at a 10-times greater risk of developing premature coronary heart disease than their counterparts without diabetes.
Undergoing Gastric Bypass Could Reduce Risk of Diabetic Retinopathy in Obese Diabetics
January 20th 2021A matched cohort study of more than 10k patients suggests undergoing gastric bypass surgery was associated with a 38% reduction in risk of developing diabetic retinopathy among obese patients with diabetes.
Insulin Levels, BMI Trajectory Help Predict Risk of Mental Health Disorders Later in Life
January 15th 2021An analysis of children from the Avon Longitudinal Study of Parents and Children is providing insight into the potential for increased risk of mental health disorders among patients with high insulin levels or high BMI trajectory as a child.
Lockdowns Led to Increases in Weight, Anxiety But Improved Glucose Control in Diabetes Patients
January 13th 2021An analysis of data from questionnaires sent to more than 400 patients from a diabetes clinic in Europe gives insight into the impact of lockdown measures on body weight, HbA1c control, and perceived levels of stress and anxiety.
Comparing Standard vs High-Dose Influenza Vaccines in High-Risk Cardiovascular Disease Patients
December 18th 2020Results of the INVESTED trial are shedding light on cardiovascular and pulmonary outcomes among patients with high-risk cardiovascular disease receiving standard-dose vs high-dose influenza vaccines.